-
1
-
-
39349083915
-
Adapting proteostasis for disease intervention
-
Balch W.E., Morimoto R.I., Dillin A., Kelly J.W. Adapting proteostasis for disease intervention. Science 2008, 319:916-919.
-
(2008)
Science
, vol.319
, pp. 916-919
-
-
Balch, W.E.1
Morimoto, R.I.2
Dillin, A.3
Kelly, J.W.4
-
2
-
-
33646127577
-
Molecular chaperones and protein quality control
-
Bukau B., Weissman J., Horwich A. Molecular chaperones and protein quality control. Cell 2006, 125:443-451.
-
(2006)
Cell
, vol.125
, pp. 443-451
-
-
Bukau, B.1
Weissman, J.2
Horwich, A.3
-
3
-
-
37649005234
-
Autophagy in the pathogenesis of disease
-
Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
-
(2008)
Cell
, vol.132
, pp. 27-42
-
-
Levine, B.1
Kroemer, G.2
-
5
-
-
0034578389
-
Aggresomes, inclusion bodies and protein aggregation
-
Kopito R.R. Aggresomes, inclusion bodies and protein aggregation. Trends in Cell Biology 2000, 10:524-530.
-
(2000)
Trends in Cell Biology
, vol.10
, pp. 524-530
-
-
Kopito, R.R.1
-
6
-
-
77953415635
-
The ubiquitin-proteasome system as a molecular target in solid tumors: an update on bortezomib
-
Milano A., Perri F., Caponigro F. The ubiquitin-proteasome system as a molecular target in solid tumors: an update on bortezomib. OncoTargets and Therapy 2009, 2:171-178.
-
(2009)
OncoTargets and Therapy
, vol.2
, pp. 171-178
-
-
Milano, A.1
Perri, F.2
Caponigro, F.3
-
7
-
-
41549133200
-
Proteasome inhibitors in cancer therapy: lessons from the first decade
-
Orlowski R.Z., Kuhn D.J. Proteasome inhibitors in cancer therapy: lessons from the first decade. Clinical Cancer Research 2008, 14:1649-1657.
-
(2008)
Clinical Cancer Research
, vol.14
, pp. 1649-1657
-
-
Orlowski, R.Z.1
Kuhn, D.J.2
-
8
-
-
0012433771
-
Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts
-
Nawrocki S.T., Bruns C.J., Harbison M.T., Bold R.J., Gotsch B.S., Abbruzzese J.L., Elliot P., Adams J., McConkey D.J. Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts. Molecular Cancer Therapeutics 2002, 1:1243-1253.
-
(2002)
Molecular Cancer Therapeutics
, vol.1
, pp. 1243-1253
-
-
Nawrocki, S.T.1
Bruns, C.J.2
Harbison, M.T.3
Bold, R.J.4
Gotsch, B.S.5
Abbruzzese, J.L.6
Elliot, P.7
Adams, J.8
McConkey, D.J.9
-
9
-
-
0642349188
-
Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts
-
Williams S., Pettaway C., Song R., Papandreou C., Logothetis C., McConkey D.J. Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts. Molecular Cancer Therapeutics 2003, 2:835-843.
-
(2003)
Molecular Cancer Therapeutics
, vol.2
, pp. 835-843
-
-
Williams, S.1
Pettaway, C.2
Song, R.3
Papandreou, C.4
Logothetis, C.5
McConkey, D.J.6
-
10
-
-
84865619844
-
Continued overall survival benefit after 5 years' follow-up with bort
-
S.F. San Miguel, R. Schlag, N.K. Khuageva, M.A. Dimopoulos, O. Shpilberg, M. Kropff, I. Spicka, M.T. Petrucci, A. Palumbo, O.S. Samoilova, A. Dmoszynska, K.M. Abdulkadyrov, M. Delforge, B. Jiang, M.-V. Mateos, K.C. Anderson, D.L. Esseltine, K. Liu, K. Deraedt, W.M. Cakana, A.Z.H. van de Velde, P.G. Richardson, Continued overall survival benefit after 5 years' follow-up with bortezomib-melphalan-prednisone (VMP) versus melphalan-prednisone (MP) in patients with previously untreated multiple myeloma, and no increased risk of second primary malignancies: final results of the phase 3 VISTA trial, in: Presented at the 52nd American Society for Hematology (ASH) Annual Meeting, 2011 (Abstract 476).
-
-
-
San Miguel, S.F.1
Schlag, R.2
Khuageva, N.K.3
Dimopoulos, M.A.4
Shpilberg, O.5
Kropff, M.6
Spicka, I.7
Petrucci, M.T.8
Palumbo, A.9
Samoilova, O.S.10
Dmoszynska, A.11
Abdulkadyrov, K.M.12
Delforge, M.13
Jiang, B.14
Mateos, M.-V.15
Anderson, K.C.16
Esseltine, D.L.17
Liu, K.18
Deraedt K19
Cakana, W.M.20
van de Velde, A.Z.H.21
Richardson, P.G.22
more..
-
11
-
-
33744832401
-
United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy
-
Kane R.C., Farrell A.T., Sridhara R., Pazdur R. United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy. Clinical Cancer Research 2006, 12:2955-2960.
-
(2006)
Clinical Cancer Research
, vol.12
, pp. 2955-2960
-
-
Kane, R.C.1
Farrell, A.T.2
Sridhara, R.3
Pazdur, R.4
-
12
-
-
34848870352
-
Bortezomib for the treatment of mantle cell lymphoma
-
Kane R.C., Dagher R., Farrell A., Ko C.W., Sridhara R., Justice R., Pazdur R. Bortezomib for the treatment of mantle cell lymphoma. Clinical Cancer Research 2007, 13:5291-5294.
-
(2007)
Clinical Cancer Research
, vol.13
, pp. 5291-5294
-
-
Kane, R.C.1
Dagher, R.2
Farrell, A.3
Ko, C.W.4
Sridhara, R.5
Justice, R.6
Pazdur, R.7
-
13
-
-
0041706156
-
A proteomics approach to understanding protein ubiquitination
-
Peng J., Schwartz D., Elias J.E., Thoreen C.C., Cheng D., Marsischky G., Roelofs J., Finley D., Gygi S.P. A proteomics approach to understanding protein ubiquitination. Nature Biotechnology 2003, 21:921-926.
-
(2003)
Nature Biotechnology
, vol.21
, pp. 921-926
-
-
Peng, J.1
Schwartz, D.2
Elias, J.E.3
Thoreen, C.C.4
Cheng, D.5
Marsischky, G.6
Roelofs, J.7
Finley, D.8
Gygi, S.P.9
-
15
-
-
0034602845
-
Recognition of the polyubiquitin proteolytic signal
-
Thrower J.S., Hoffman L., Rechsteiner M., Pickart C.M. Recognition of the polyubiquitin proteolytic signal. European Molecular Biology Organization Journal 2000, 19:94-102.
-
(2000)
European Molecular Biology Organization Journal
, vol.19
, pp. 94-102
-
-
Thrower, J.S.1
Hoffman, L.2
Rechsteiner, M.3
Pickart, C.M.4
-
17
-
-
11244257361
-
Enzymic content of the mitochondria fraction
-
De Duve C C., Gianetto R., Appelmans F., Wattiaux R. Enzymic content of the mitochondria fraction. Nature (London) 1953, 172:1143-1144.
-
(1953)
Nature (London)
, vol.172
, pp. 1143-1144
-
-
De Duve, C.C.1
Gianetto, R.2
Appelmans, F.3
Wattiaux, R.4
-
18
-
-
77956410115
-
Selective autophagy: ubiquitin-mediated recognition and beyond
-
Kraft C., Peter M., Hofmann K. Selective autophagy: ubiquitin-mediated recognition and beyond. Nature Cell Biology 2010, 12:836-841.
-
(2010)
Nature Cell Biology
, vol.12
, pp. 836-841
-
-
Kraft, C.1
Peter, M.2
Hofmann, K.3
-
19
-
-
65549142204
-
A role for ubiquitin in selective autophagy
-
Kirkin V., McEwan D.G., Novak I., Dikic I. A role for ubiquitin in selective autophagy. Molecular Cell 2010, 34:259-269.
-
(2010)
Molecular Cell
, vol.34
, pp. 259-269
-
-
Kirkin, V.1
McEwan, D.G.2
Novak, I.3
Dikic, I.4
-
20
-
-
25444440875
-
The role of autophagy in cancer development and response to therapy
-
Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nature Reviews Cancer 2005, 5:726-734.
-
(2005)
Nature Reviews Cancer
, vol.5
, pp. 726-734
-
-
Kondo, Y.1
Kanzawa, T.2
Sawaya, R.3
Kondo, S.4
-
21
-
-
8344242220
-
Autophagy in health and disease: a double-edged sword
-
Shintani T., Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 2004, 306:990-995.
-
(2004)
Science
, vol.306
, pp. 990-995
-
-
Shintani, T.1
Klionsky, D.J.2
-
22
-
-
77951750296
-
Selective autophagy in cancer development and therapy
-
Dikic I., Johansen T., Kirkin V. Selective autophagy in cancer development and therapy. Cancer Research 2010, 70:3431-3434.
-
(2010)
Cancer Research
, vol.70
, pp. 3431-3434
-
-
Dikic, I.1
Johansen, T.2
Kirkin, V.3
-
24
-
-
0346020435
-
The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress
-
Kawaguchi Y., Kovacs J.J., McLaurin A., Vance J.M., Ito A., Yao T.P. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 2003, 115:727-738.
-
(2003)
Cell
, vol.115
, pp. 727-738
-
-
Kawaguchi, Y.1
Kovacs, J.J.2
McLaurin, A.3
Vance, J.M.4
Ito, A.5
Yao, T.P.6
-
25
-
-
0035146685
-
The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins
-
Connell P., Ballinger C.A., Jiang J., Wu Y., Thompson L.J., Höhfeld J., Patterson C. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nature Cell Biology 2001, 3:93-96.
-
(2001)
Nature Cell Biology
, vol.3
, pp. 93-96
-
-
Connell, P.1
Ballinger, C.A.2
Jiang, J.3
Wu, Y.4
Thompson, L.J.5
Höhfeld, J.6
Patterson, C.7
-
26
-
-
0035142877
-
The Hsc70 cochaperone CHIP targets immature CFTR for proteasomal degradation
-
Meacham G.C., Patterson C., Zhang W., Younger J.M., Cyr D.M. The Hsc70 cochaperone CHIP targets immature CFTR for proteasomal degradation. Nature Cell Biology 2001, 3:100-105.
-
(2001)
Nature Cell Biology
, vol.3
, pp. 100-105
-
-
Meacham, G.C.1
Patterson, C.2
Zhang, W.3
Younger, J.M.4
Cyr, D.M.5
-
27
-
-
77649337122
-
HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy
-
Lee J.Y., Koga H., Kawaguchi Y., Tang W., Wong E., Gao Y.S., Pandey U.B., Kaushik S., Tresse E., Lu J., Taylor J.P., Cuervo A.M., Yao T.P. HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. European Molecular Biology Organization Journal 2010, 29:969-980.
-
(2010)
European Molecular Biology Organization Journal
, vol.29
, pp. 969-980
-
-
Lee, J.Y.1
Koga, H.2
Kawaguchi, Y.3
Tang, W.4
Wong, E.5
Gao, Y.S.6
Pandey, U.B.7
Kaushik, S.8
Tresse, E.9
Lu, J.10
Taylor, J.P.11
Cuervo, A.M.12
Yao, T.P.13
-
28
-
-
77953711220
-
Quality control autophagy: a joint effort of ubiquitin, protein deacetylase and actin cytoskeleton
-
Lee J.Y., Yao T.P. Quality control autophagy: a joint effort of ubiquitin, protein deacetylase and actin cytoskeleton. Autophagy 2010, 6:555-557.
-
(2010)
Autophagy
, vol.6
, pp. 555-557
-
-
Lee, J.Y.1
Yao, T.P.2
-
29
-
-
40749161986
-
Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally
-
Zhang Y., Kwon S., Yamaguchi T., Cubizolles F., Rousseaux S., Kneissel M., Cao C., Li N., Cheng H.L., Chua K., Lombard D., Mizeracki A., Matthias G., Alt F.W., Khochbin S., Matthias P. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Molecular and Cellular Biology 2008, 28:1688-1701.
-
(2008)
Molecular and Cellular Biology
, vol.28
, pp. 1688-1701
-
-
Zhang, Y.1
Kwon, S.2
Yamaguchi, T.3
Cubizolles, F.4
Rousseaux, S.5
Kneissel, M.6
Cao, C.7
Li, N.8
Cheng, H.L.9
Chua, K.10
Lombard, D.11
Mizeracki, A.12
Matthias, G.13
Alt, F.W.14
Khochbin, S.15
Matthias, P.16
-
30
-
-
34250183177
-
HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS
-
Pandey U.B., Nie Z., Batlevi Y., McCray B.A., Ritson G.P., Nedelsky N.B., Schwartz S.L., DiProspero N.A., Knight M.A., Schuldner O., Padmanabhan R., Hild M., Berry D.L., Garza D., Hubbert C.C., Yao T.P., Baehrecke E.H., Taylor J.P. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007, 447:859-863.
-
(2007)
Nature
, vol.447
, pp. 859-863
-
-
Pandey, U.B.1
Nie, Z.2
Batlevi, Y.3
McCray, B.A.4
Ritson, G.P.5
Nedelsky, N.B.6
Schwartz, S.L.7
DiProspero, N.A.8
Knight, M.A.9
Schuldner, O.10
Padmanabhan, R.11
Hild, M.12
Berry, D.L.13
Garza, D.14
Hubbert, C.C.15
Yao, T.P.16
Baehrecke, E.H.17
Taylor, J.P.18
-
31
-
-
33750363298
-
The roles of intracellular protein-degradation pathways in neurodegeneration
-
Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006, 443:780-786.
-
(2006)
Nature
, vol.443
, pp. 780-786
-
-
Rubinsztein, D.C.1
-
32
-
-
60849099049
-
A role for NBR1 in autophagosomal degradation of ubiquitinated substrates
-
Kirkin V., Lamark T., Sou Y.S., Bjørkøy G., Nunn J.L., Bruun J.A., Shvets E., McEwan G., Clausen T.H., Wild P., Bilusic P., Theurillat J.P., Øvervatn A., Ishii T., Elazar Z., Komatsu M., Dikic I., Johansen T. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Molecular Cell 2009, 33:505-516.
-
(2009)
Molecular Cell
, vol.33
, pp. 505-516
-
-
Kirkin, V.1
Lamark, T.2
Sou, Y.S.3
Bjørkøy, G.4
Nunn, J.L.5
Bruun, J.A.6
Shvets, E.7
McEwan, G.8
Clausen, T.H.9
Wild, P.10
Bilusic, P.11
Theurillat, J.P.12
Øvervatn, A.13
Ishii, T.14
Elazar, Z.15
Komatsu, M.16
Dikic, I.17
Johansen, T.18
-
33
-
-
67650517556
-
NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets
-
Lamark T., Kirkin V., Dikic I., Johansen T. NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle 2009, 8:1986-1990.
-
(2009)
Cell Cycle
, vol.8
, pp. 1986-1990
-
-
Lamark, T.1
Kirkin, V.2
Dikic, I.3
Johansen, T.4
-
34
-
-
36849089101
-
Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice
-
Komatsu M., Waguri S., Koike M., Sou Y.S., Ueno T., Hara T., Mizushima N., Iwata J., Ezaki J., Murata S., Hamazaki J., Nishito Y., Iemura S., Natsume T., Yanagawa T., Uwayama J., Warabi E., Yoshida H., Ishii T., Kobayashi A., Yamamoto M., Yue Z., Uchiyama Y., Kominami E., Tanaka K. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007, 131:1149-1159.
-
(2007)
Cell
, vol.131
, pp. 1149-1159
-
-
Komatsu, M.1
Waguri, S.2
Koike, M.3
Sou, Y.S.4
Ueno, T.5
Hara, T.6
Mizushima, N.7
Iwata, J.8
Ezaki, J.9
Murata, S.10
Hamazaki, J.11
Nishito, Y.12
Iemura, S.13
Natsume, T.14
Yanagawa, T.15
Uwayama, J.16
Warabi, E.17
Yoshida, H.18
Ishii, T.19
Kobayashi, A.20
Yamamoto, M.21
Yue, Z.22
Uchiyama, Y.23
Kominami, E.24
Tanaka, K.25
more..
-
35
-
-
67650234499
-
NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets
-
Kirkin V., Lamark T., Johansen T., Dikic I. NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets. Autophagy 2009, 5:732-733.
-
(2009)
Autophagy
, vol.5
, pp. 732-733
-
-
Kirkin, V.1
Lamark, T.2
Johansen, T.3
Dikic, I.4
-
36
-
-
80052363973
-
Plant NBR1 is a selective autophagy substrate and functional hybrid of the mammalian autophagic adapters NBR1 and p62/SQSTM1
-
Svenning S., Lamark T., Krause K., Johansen T. Plant NBR1 is a selective autophagy substrate and functional hybrid of the mammalian autophagic adapters NBR1 and p62/SQSTM1. Autophagy 2011, 7:993-1010.
-
(2011)
Autophagy
, vol.7
, pp. 993-1010
-
-
Svenning, S.1
Lamark, T.2
Krause, K.3
Johansen, T.4
-
38
-
-
41949134141
-
Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch
-
Long J., Gallagher T.R., Cavey J.R., Sheppard P.W., Ralston S.H., Layfield R., Searle M.S. Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch. Journal of Biological Chemistry 2008, 283:5427-5440.
-
(2008)
Journal of Biological Chemistry
, vol.283
, pp. 5427-5440
-
-
Long, J.1
Gallagher, T.R.2
Cavey, J.R.3
Sheppard, P.W.4
Ralston, S.H.5
Layfield, R.6
Searle, M.S.7
-
39
-
-
38349114036
-
Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases
-
Tan J.M., Wong E.S., Kirkpatrick D.S., Pletnikova O., Ko H.S., Tay S.P., Ho M.W., Troncoso J., Gygi S.P., Lee M.K., Dawson V.L., Dawson T.M., Kim K.L. Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Human Molecular Genetics 2008, 17:431-439.
-
(2008)
Human Molecular Genetics
, vol.17
, pp. 431-439
-
-
Tan, J.M.1
Wong, E.S.2
Kirkpatrick, D.S.3
Pletnikova, O.4
Ko, H.S.5
Tay, S.P.6
Ho, M.W.7
Troncoso, J.8
Gygi, S.P.9
Lee, M.K.10
Dawson, V.L.11
Dawson, T.M.12
Kim, K.L.13
-
40
-
-
42049100859
-
Essential role of sequestosome1/p62 in regulating accumulation of Lys63-ubiquitinated proteins
-
Wooten M.W., Geetha T., Babu J.R., Seibenhener M.L., Peng J., Cox N., Diaz-Meco M.T., Moscat J. Essential role of sequestosome1/p62 in regulating accumulation of Lys63-ubiquitinated proteins. Journal of Biological Chemistry 2008, 283:6783-6789.
-
(2008)
Journal of Biological Chemistry
, vol.283
, pp. 6783-6789
-
-
Wooten, M.W.1
Geetha, T.2
Babu, J.R.3
Seibenhener, M.L.4
Peng, J.5
Cox, N.6
Diaz-Meco, M.T.7
Moscat, J.8
-
41
-
-
60549093730
-
Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates
-
Korolchuk V., Mansilla A., Menzies F.M., Rubinsztein D.C. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Molecular Cell 2009, 33:517-527.
-
(2009)
Molecular Cell
, vol.33
, pp. 517-527
-
-
Korolchuk, V.1
Mansilla, A.2
Menzies, F.M.3
Rubinsztein, D.C.4
-
42
-
-
15344339092
-
-
Cavey J.R., Ralston S.H., Hocking L.J., Sheppard P.W., Ciani B., Searle M.S., Layfield R. Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations. Journal of Bone and Mineral Research 2005, 20:619-624.
-
(2005)
Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations. Journal of Bone and Mineral Research
, vol.20
, pp. 619-624
-
-
Cavey, J.R.1
Ralston, S.H.2
Hocking, L.J.3
Sheppard, P.W.4
Ciani, B.5
Searle, M.S.6
Layfield, R.7
-
43
-
-
65549142204
-
A role for ubiquitin in selective autophagy
-
Kirkin V., McEwan D.G., Novak I., Dikic I. A role for ubiquitin in selective autophagy. Molecular Cell 2009, 34:259-269.
-
(2009)
Molecular Cell
, vol.34
, pp. 259-269
-
-
Kirkin, V.1
McEwan, D.G.2
Novak, I.3
Dikic, I.4
-
44
-
-
60849099049
-
A role for NBR1 in autophagosomal degradation of ubiquitinated substrates
-
Kirkin V., Lamark T., Sou Y.S., Bjorkov G., Nunn J.L., Bruun J.A., Shvets E., McEwan D.G., Clausen T.H., Wild P., Bilusic I., Theurillat J.P., Øvervatn A., Ishii T., Elazar Z., Komatsu M., Dikic I., Johansen T. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Molecular Cell 2009, 33:505-516.
-
(2009)
Molecular Cell
, vol.33
, pp. 505-516
-
-
Kirkin, V.1
Lamark, T.2
Sou, Y.S.3
Bjorkov, G.4
Nunn, J.L.5
Bruun, J.A.6
Shvets, E.7
McEwan, D.G.8
Clausen, T.H.9
Wild, P.10
Bilusic, I.11
Theurillat, J.P.12
Øvervatn, A.13
Ishii, T.14
Elazar, Z.15
Komatsu, M.16
Dikic, I.17
Johansen, T.18
-
45
-
-
77952533111
-
VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD
-
Tresse E., Salomons F.A., Bott L.C., Kimonis V., Yao T.P., Dantuma N.P., Taylor J.P. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 2010, 6:217-227.
-
(2010)
Autophagy
, vol.6
, pp. 217-227
-
-
Tresse, E.1
Salomons, F.A.2
Bott, L.C.3
Kimonis, V.4
Yao, T.P.5
Dantuma, N.P.6
Taylor, J.P.7
-
46
-
-
33846696670
-
Ubiquitin ligase Hrd1 enhances the degradation and suppresses the toxicity of polyglutamine-expanded huntingtin
-
Yang H., Zhong X., Ballar P., Luo S., Shen Y., Rubinsztein D.C., Monteiro M.J., Fang S. Ubiquitin ligase Hrd1 enhances the degradation and suppresses the toxicity of polyglutamine-expanded huntingtin. Experimental Cell Research 2007, 313:538-550.
-
(2007)
Experimental Cell Research
, vol.313
, pp. 538-550
-
-
Yang, H.1
Zhong, X.2
Ballar, P.3
Luo, S.4
Shen, Y.5
Rubinsztein, D.C.6
Monteiro, M.J.7
Fang, S.8
-
47
-
-
0035163063
-
Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways
-
Seigneurin-Berny D., Verdel A., Curtet S., Lemercier C., Garin J., Rousseaux S., Khochbin S. Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways. Molecular and Cell Biology 2001, 21:8035-8044.
-
(2001)
Molecular and Cell Biology
, vol.21
, pp. 8035-8044
-
-
Seigneurin-Berny, D.1
Verdel, A.2
Curtet, S.3
Lemercier, C.4
Garin, J.5
Rousseaux, S.6
Khochbin, S.7
-
48
-
-
20044386298
-
Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation
-
Lim K.L., Chew K.C., Tan J.M., Wang C., Chung K.K., Zhang Y., Tanaka Y., Smith W.L., Engelender S., Ross C.A., Dawson V.L., Dawson T.M. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. Journal Neurosciences 2005, 25:2002-2009.
-
(2005)
Journal Neurosciences
, vol.25
, pp. 2002-2009
-
-
Lim, K.L.1
Chew, K.C.2
Tan, J.M.3
Wang, C.4
Chung, K.K.5
Zhang, Y.6
Tanaka, Y.7
Smith, W.L.8
Engelender, S.9
Ross, C.A.10
Dawson, V.L.11
Dawson, T.M.12
-
49
-
-
33344456519
-
Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases?
-
Lim K.L., Dawson V.L., Dawson T.M. Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases?. Neurobiology of Aging 2006, 27:524-529.
-
(2006)
Neurobiology of Aging
, vol.27
, pp. 524-529
-
-
Lim, K.L.1
Dawson, V.L.2
Dawson, T.M.3
-
50
-
-
0034700158
-
Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1
-
Zhang Y., Gao J., Chung K.K., Huang H., Dawson V.L., Dawson T.M. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proceedings of the National Academy of Sciences of the United States 2000, 97:13354-13359.
-
(2000)
Proceedings of the National Academy of Sciences of the United States
, vol.97
, pp. 13354-13359
-
-
Zhang, Y.1
Gao, J.2
Chung, K.K.3
Huang, H.4
Dawson, V.L.5
Dawson, T.M.6
-
52
-
-
78049495046
-
Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection
-
Riley B.E., Kaiser S.E., Shaler T.A., Ng A.C.Y., Hara T., Hipp M.S., Lage K., Xavier R.J., Ryu K.Y., Taguchi K., Yamamoto M., Tanaka K., Mizushima N., Komatsu M., Kopito R.R. Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection. Journal of Cell Biology 2010, 191:537-552.
-
(2010)
Journal of Cell Biology
, vol.191
, pp. 537-552
-
-
Riley, B.E.1
Kaiser, S.E.2
Shaler, T.A.3
Ng, A.C.Y.4
Hara, T.5
Hipp, M.S.6
Lage, K.7
Xavier, R.J.8
Ryu, K.Y.9
Taguchi, K.10
Yamamoto, M.11
Tanaka, K.12
Mizushima, N.13
Komatsu, M.14
Kopito, R.R.15
-
53
-
-
34248139628
-
Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae
-
Suzuki K., Ohsumi Y. Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae. Federation of European Biochemical Societies Letters 2007, 581:2156-2161.
-
(2007)
Federation of European Biochemical Societies Letters
, vol.581
, pp. 2156-2161
-
-
Suzuki, K.1
Ohsumi, Y.2
-
54
-
-
67649467294
-
Dynamics and diversity in autophagy mechanisms: lessons from yeast
-
Nakatogawa H., Suzuki K., Kamada Y., Ohsumi Y. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nature Reviews Molecular Cell Biology 2009, 10:458-467.
-
(2009)
Nature Reviews Molecular Cell Biology
, vol.10
, pp. 458-467
-
-
Nakatogawa, H.1
Suzuki, K.2
Kamada, Y.3
Ohsumi, Y.4
-
55
-
-
33847705665
-
Role of ubiquitin- and Ubl-binding proteins in cell signaling
-
Kirkin V., Dikic I. Role of ubiquitin- and Ubl-binding proteins in cell signaling. Current Opinion on Cell Biology 2007, 19:199-205.
-
(2007)
Current Opinion on Cell Biology
, vol.19
, pp. 199-205
-
-
Kirkin, V.1
Dikic, I.2
-
56
-
-
0005677775
-
3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes
-
Seglen P.O., Gordon P.B. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proceedings of the National Academy of Sciences of the United States 1982, 79:1889-1892.
-
(1982)
Proceedings of the National Academy of Sciences of the United States
, vol.79
, pp. 1889-1892
-
-
Seglen, P.O.1
Gordon, P.B.2
-
57
-
-
67651146528
-
Effect of autophagy on multiple myeloma cell viability
-
Hoang B., Benavides A., Shi Y., Frost P., Lichtenstein A. Effect of autophagy on multiple myeloma cell viability. Molecular Cancer Therapeutics 2009, 8:1974-1984.
-
(2009)
Molecular Cancer Therapeutics
, vol.8
, pp. 1974-1984
-
-
Hoang, B.1
Benavides, A.2
Shi, Y.3
Frost, P.4
Lichtenstein, A.5
-
58
-
-
19944434059
-
Inhibition of macroautophagy triggers apoptosis
-
Boya P., Gonzalez-Polo R., Casares N., Perfettini J.L., Dessen P., Larcochette N., Metvier D., Meley D., Souquere S., Yoshimori T., Pierron G., Codogno P., Kroemer G. Inhibition of macroautophagy triggers apoptosis. Molecular and Cellular Biology 2005, 25:1025-1040.
-
(2005)
Molecular and Cellular Biology
, vol.25
, pp. 1025-1040
-
-
Boya, P.1
Gonzalez-Polo, R.2
Casares, N.3
Perfettini, J.L.4
Dessen, P.5
Larcochette, N.6
Metvier, D.7
Meley, D.8
Souquere, S.9
Yoshimori, T.10
Pierron, G.11
Codogno, P.12
Kroemer, G.13
-
59
-
-
53049083867
-
Mechanisms of proteasome inhibitor action and resistance in cancer
-
McConkey D.J., Zhu K. Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resistance Updates 2008, 11:164-179.
-
(2008)
Drug Resistance Updates
, vol.11
, pp. 164-179
-
-
McConkey, D.J.1
Zhu, K.2
-
60
-
-
75149175502
-
Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells
-
Zhu K., Dunner K., McConkey D.J. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 2010, 29:451-462.
-
(2010)
Oncogene
, vol.29
, pp. 451-462
-
-
Zhu, K.1
Dunner, K.2
McConkey, D.J.3
-
61
-
-
80052697287
-
The role of autophagy in cancer: therapeutic implications
-
Yang Z., Chee C.E., Huang S., Sinicrope F.A. The role of autophagy in cancer: therapeutic implications. Molecular Cancer Therapeutics 2011, 10:1533-1541.
-
(2011)
Molecular Cancer Therapeutics
, vol.10
, pp. 1533-1541
-
-
Yang, Z.1
Chee, C.E.2
Huang, S.3
Sinicrope, F.A.4
-
62
-
-
50349098812
-
Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells
-
Han J., Hou W., Goldstein L.A., Lu C., Stolz D.B., Yin X.M., Rabinowich H. Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells. Journal of Biological Chemistry 2008, 283:19665-19677.
-
(2008)
Journal of Biological Chemistry
, vol.283
, pp. 19665-19677
-
-
Han, J.1
Hou, W.2
Goldstein, L.A.3
Lu, C.4
Stolz, D.B.5
Yin, X.M.6
Rabinowich, H.7
-
63
-
-
33745859721
-
Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolide-induced neuroprotection
-
Shacka J.J., Klocke B.J., Roth K.A. Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolide-induced neuroprotection. Autophagy 2006, 2:228-230.
-
(2006)
Autophagy
, vol.2
, pp. 228-230
-
-
Shacka, J.J.1
Klocke, B.J.2
Roth, K.A.3
-
64
-
-
70350365288
-
Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux
-
Rossi M., Munarriz E.R., Bartesaghi S., Milanese M., Dinsdale D., Guerra-Martin M.A., Bampton E.T., Glynn P., Bonanno G., Knight R.A., Nicotera P., Melino G. Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux. Journal of Cell Science 2009, 122:3330-3339.
-
(2009)
Journal of Cell Science
, vol.122
, pp. 3330-3339
-
-
Rossi, M.1
Munarriz, E.R.2
Bartesaghi, S.3
Milanese, M.4
Dinsdale, D.5
Guerra-Martin, M.A.6
Bampton, E.T.7
Glynn, P.8
Bonanno, G.9
Knight, R.A.10
Nicotera, P.11
Melino, G.12
-
65
-
-
67651155954
-
Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy
-
Ding W.X., Ni H.M., Gao W., Chen X., Kang J.H., Stolz D.B., Liu J., Yin X.M. Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy. Molecular Cancer Therapeutics 2009, 8(7):2036-2045.
-
(2009)
Molecular Cancer Therapeutics
, vol.8
, Issue.7
, pp. 2036-2045
-
-
Ding, W.X.1
Ni, H.M.2
Gao, W.3
Chen, X.4
Kang, J.H.5
Stolz, D.B.6
Liu, J.7
Yin, X.M.8
-
66
-
-
33845459165
-
Autophagy is activated for cell survival after endoplasmic reticulum stress
-
Ogata M., Hino S., Saito A., Morikawa K., Kondo S., Kanemoto S., Murakami T., Taniguchi M., Tanii I., Yoshinaga K., Shiosaka S., Hammarback J.A., Urano F., Imaizumi K. Autophagy is activated for cell survival after endoplasmic reticulum stress. Molecular and Cellular Biology 2006, 26:9220-9231.
-
(2006)
Molecular and Cellular Biology
, vol.26
, pp. 9220-9231
-
-
Ogata, M.1
Hino, S.2
Saito, A.3
Morikawa, K.4
Kondo, S.5
Kanemoto, S.6
Murakami, T.7
Taniguchi, M.8
Tanii, I.9
Yoshinaga, K.10
Shiosaka, S.11
Hammarback, J.A.12
Urano, F.13
Imaizumi, K.14
-
67
-
-
79959344464
-
Autophaghic and apoptotic effects of HDAC inhibitors on cancer cells
-
Article ID 803260
-
Rikiishi H. Autophaghic and apoptotic effects of HDAC inhibitors on cancer cells. Journal of Biomedicine and Biotechnology 2011, 11. Article ID 803260.
-
(2011)
Journal of Biomedicine and Biotechnology
, vol.11
-
-
Rikiishi, H.1
-
68
-
-
67449138841
-
Epigenetic modifiers: basic understanding and clinical development
-
Piekarz R.L., Bates S.E. Epigenetic modifiers: basic understanding and clinical development. Clinical Cancer Research 2009, 15:3918-3926.
-
(2009)
Clinical Cancer Research
, vol.15
, pp. 3918-3926
-
-
Piekarz, R.L.1
Bates, S.E.2
-
69
-
-
84855424390
-
Interplay between histone deacetylases and autophagy - from cancer therapy to neurodegeneration
-
True O., Matthias P. Interplay between histone deacetylases and autophagy - from cancer therapy to neurodegeneration. Immunology and Cell Biology 2012, 90:78-84.
-
(2012)
Immunology and Cell Biology
, vol.90
, pp. 78-84
-
-
True, O.1
Matthias, P.2
-
71
-
-
20844435806
-
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma
-
Hideshima T., Bradner J.E., Wong J., Chauhan D., Richardson P., Schreiber S.L., Anderson K.C. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. Proceedings of the National Academy of Science of the United States 2005, 102:8567-8572.
-
(2005)
Proceedings of the National Academy of Science of the United States
, vol.102
, pp. 8567-8572
-
-
Hideshima, T.1
Bradner, J.E.2
Wong, J.3
Chauhan, D.4
Richardson, P.5
Schreiber, S.L.6
Anderson, K.C.7
-
72
-
-
33751172982
-
Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells
-
Catley L., Weisberg E., Kiziltepe T., Tai Y.T., Hideshima T., Tassone P., Atadja P., Chauhan D., Munshi N.C., Anderson K.C. Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells. Blood 2006, 108:3441-3449.
-
(2006)
Blood
, vol.108
, pp. 3441-3449
-
-
Catley, L.1
Weisberg, E.2
Kiziltepe, T.3
Tai, Y.T.4
Hideshima, T.5
Tassone, P.6
Atadja, P.7
Chauhan, D.8
Munshi, N.C.9
Anderson, K.C.10
-
73
-
-
34347394714
-
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance
-
Carew J.S., Nawrocki S.T., Kahue C.N., Zhang H., Yang C., Chung L., Houghton J.A., Huang P., Giles F.J., Cleveland J.L. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 2007, 110:313-322.
-
(2007)
Blood
, vol.110
, pp. 313-322
-
-
Carew, J.S.1
Nawrocki, S.T.2
Kahue, C.N.3
Zhang, H.4
Yang, C.5
Chung, L.6
Houghton, J.A.7
Huang, P.8
Giles, F.J.9
Cleveland, J.L.10
-
74
-
-
79953659370
-
Autophagy blockade enhances HDAC inhibitors' pro-apoptotic effects: potential implications for the treatment of a therapeutic-resistant malignancy
-
Lopez G., Torres K., Lev D. Autophagy blockade enhances HDAC inhibitors' pro-apoptotic effects: potential implications for the treatment of a therapeutic-resistant malignancy. Autophagy 2011, 7:440-441.
-
(2011)
Autophagy
, vol.7
, pp. 440-441
-
-
Lopez, G.1
Torres, K.2
Lev, D.3
-
75
-
-
77955884095
-
Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells
-
Li J., Liu R., Lei Y., Wang K., Lau Q.C., Xie N., Zhou S., Nie C., Chen L., Wei Y., Huang C. Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells. Autophagy 2010, 6:711-724.
-
(2010)
Autophagy
, vol.6
, pp. 711-724
-
-
Li, J.1
Liu, R.2
Lei, Y.3
Wang, K.4
Lau, Q.C.5
Xie, N.6
Zhou, S.7
Nie, C.8
Chen, L.9
Wei, Y.10
Huang, C.11
-
76
-
-
82955170653
-
Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis which is opposed by the induction of autophagy
-
Thomas S., Thurn K.T., Bicaku E., Marchion D.C., Munster P.N. Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis which is opposed by the induction of autophagy. Breast Cancer Research and Treatment 2011, 130:437-447.
-
(2011)
Breast Cancer Research and Treatment
, vol.130
, pp. 437-447
-
-
Thomas, S.1
Thurn, K.T.2
Bicaku, E.3
Marchion, D.C.4
Munster, P.N.5
-
77
-
-
83455234742
-
A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma
-
Harrison S.J., Quach H., Link E., Seymour J.F., Ritchie D.S., Ruell S., Dean J., Januszewicz H., Johnstone R., Neeson P., Dickinson M., Nichols J., Prince H.M. A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma. Blood 2011, 118:6274-6283.
-
(2011)
Blood
, vol.118
, pp. 6274-6283
-
-
Harrison, S.J.1
Quach, H.2
Link, E.3
Seymour, J.F.4
Ritchie, D.S.5
Ruell, S.6
Dean, J.7
Januszewicz, H.8
Johnstone, R.9
Neeson, P.10
Dickinson, M.11
Nichols, J.12
Prince, H.M.13
-
78
-
-
78649299438
-
Autophagy potentiates the anticancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma
-
Liu Y.L., Yang P.M., Shun C.T., Wu M.S., Weng J.R., Chen C.C. Autophagy potentiates the anticancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. Autophagy 2010, 6:1057-1065.
-
(2010)
Autophagy
, vol.6
, pp. 1057-1065
-
-
Liu, Y.L.1
Yang, P.M.2
Shun, C.T.3
Wu, M.S.4
Weng, J.R.5
Chen, C.C.6
-
79
-
-
79956003265
-
Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA-damaging chemotherapy
-
Pan Y., Gao Y., Chen L., Gao G., Dong H., Yang Y., Dong B., Chen X. Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA-damaging chemotherapy. Clinical Cancer Research 2011, 17:3248-3258.
-
(2011)
Clinical Cancer Research
, vol.17
, pp. 3248-3258
-
-
Pan, Y.1
Gao, Y.2
Chen, L.3
Gao, G.4
Dong, H.5
Yang, Y.6
Dong, B.7
Chen, X.8
-
80
-
-
80053554108
-
Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation
-
Ding Z.B., Hui B., Shi Y.H., Zhou J., Peng Y.F., Gu C.Y., Yang H., Shi G.M., Ke A.W., Wang X.Y., Song K., Dai Z., Shen Y.H., Fan J. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation. Clinical Cancer Research 2011, 17:6229-6238.
-
(2011)
Clinical Cancer Research
, vol.17
, pp. 6229-6238
-
-
Ding, Z.B.1
Hui, B.2
Shi, Y.H.3
Zhou, J.4
Peng, Y.F.5
Gu, C.Y.6
Yang, H.7
Shi, G.M.8
Ke, A.W.9
Wang, X.Y.10
Song, K.11
Dai, Z.12
Shen, Y.H.13
Fan, J.14
-
81
-
-
40449086885
-
Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy
-
Apel A., Herr I., Schwarz H., Rodemann H.P., Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Research 2008, 68:1485-1494.
-
(2008)
Cancer Research
, vol.68
, pp. 1485-1494
-
-
Apel, A.1
Herr, I.2
Schwarz, H.3
Rodemann, H.P.4
Mayer, A.5
-
82
-
-
79951847989
-
Principles and current strategies for targeting autophagy for cancer treatment
-
Amaravadi R.K., Lippincott-Schwartz J., Yin X.M., Weiss W., Takebe N., Timmer W., DiPaola R.S., Lotze M.T., White E. Principles and current strategies for targeting autophagy for cancer treatment. Clinical Cancer Research 2011, 15:654-666.
-
(2011)
Clinical Cancer Research
, vol.15
, pp. 654-666
-
-
Amaravadi, R.K.1
Lippincott-Schwartz, J.2
Yin, X.M.3
Weiss, W.4
Takebe, N.5
Timmer, W.6
DiPaola, R.S.7
Lotze, M.T.8
White, E.9
-
83
-
-
69949106925
-
The double-edged sword of autophagy modulation in cancer
-
White E., DiPaola R.S. The double-edged sword of autophagy modulation in cancer. Clinical Cancer Research 2009, 15:5308-5316.
-
(2009)
Clinical Cancer Research
, vol.15
, pp. 5308-5316
-
-
White, E.1
DiPaola, R.S.2
-
84
-
-
37549056216
-
The roles of therapy-induced autophagy and necrosis in cancer treatment
-
Amaravadi R.K., Thompson C.B. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clinical Cancer Research 2007, 13:7271-7279.
-
(2007)
Clinical Cancer Research
, vol.13
, pp. 7271-7279
-
-
Amaravadi, R.K.1
Thompson, C.B.2
-
86
-
-
84865658661
-
Combined autophagy and proteasome inhibition for multiple myeloma
-
in: Presente
-
D.T. Vogl, E.A. Stadtmauer, J. Bradner, L. Davis, T. Paul, E.C. Scott, C.W. Nichols, D.L. Porter, M. Carroll, J. Kaplan, G. Mallon, C.R. Swider, P.A. Mangan, B.K. Shelly, R.K. Amaravadi, Combined autophagy and proteasome inhibition for multiple myeloma: final results of a phase 1 trial of hydroxychloroquine and standard dose bortezomib for patients with relapsed or refractory myeloma, in: Presented at the 52nd American Society for Hematology (ASH) Annual Meeting, 2011 (Abstract 1869).
-
final results of a phase 1 trial of hydroxychloroquine and standard dose bortezomib for patients with relapsed or refractory myeloma
-
-
Vogl, D.T.1
Stadtmauer, E.A.2
Bradner, J.3
Davis, L.4
Paul, T.5
Scott E.C.Nichols, C.W.6
Porter, D.L.7
Carroll, M.8
Kaplan, J.9
Mallon, G.10
Swider, C.R.11
Mangan, P.A.12
Shelly, B.K.13
Amaravadi, R.K.14
-
87
-
-
53049106912
-
Molecular basis of bortezomib resistance. proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
-
Oerlemans R., Franke N.E., Assaraf Y.G., Cloos J., van Zantwijk I., Berkers C.R., Scheffer G.L., Debipersad K., Vojtekova K., Lemos C., van der Heijden J.W., Yistra B., Peterts G.J., Kaspers G.L., Dijkmans B.A., Scheper R.J., Jansen G. Molecular basis of bortezomib resistance. proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein. Blood 2008, 112:2489-2499.
-
(2008)
Blood
, vol.112
, pp. 2489-2499
-
-
Oerlemans, R.1
Franke, N.E.2
Assaraf, Y.G.3
Cloos, J.4
van Zantwijk, I.5
Berkers, C.R.6
Scheffer, G.L.7
Debipersad, K.8
Vojtekova, K.9
Lemos, C.10
van der Heijden, J.W.11
Yistra, B.12
Peterts, G.J.13
Kaspers, G.L.14
Dijkmans, B.A.15
Scheper, R.J.16
Jansen, G.17
-
88
-
-
79951690310
-
Second generation proteasome inhibitors: carfilzomib and immunoproteasome-specific inhibitors (IPSIs)
-
Kuhn D.J., Orlowski R., Bjorklund C. Second generation proteasome inhibitors: carfilzomib and immunoproteasome-specific inhibitors (IPSIs). Current Cancer Drug Targets 2011, 11:285-295.
-
(2011)
Current Cancer Drug Targets
, vol.11
, pp. 285-295
-
-
Kuhn, D.J.1
Orlowski, R.2
Bjorklund, C.3
-
89
-
-
77649237033
-
Building on bortezomib: second generation proteasome inhibitors as anti-cancer therapy
-
Dick L.R., Fleming P.E. Building on bortezomib: second generation proteasome inhibitors as anti-cancer therapy. Drug Discovery Today 2010, 15:243-249.
-
(2010)
Drug Discovery Today
, vol.15
, pp. 243-249
-
-
Dick, L.R.1
Fleming, P.E.2
-
90
-
-
84863098088
-
Autophagy in tumorigenesis and cancer therapy: Dr. Jekyll or Mr. Hyde?
-
Zhou S., Zhao L., Kuang M., Zhang B., Liang Z., Yi T., Wei Y., Zhao X. Autophagy in tumorigenesis and cancer therapy: Dr. Jekyll or Mr. Hyde?. Cancer Letters 2012, 323:115-127.
-
(2012)
Cancer Letters
, vol.323
, pp. 115-127
-
-
Zhou, S.1
Zhao, L.2
Kuang, M.3
Zhang, B.4
Liang, Z.5
Yi, T.6
Wei, Y.7
Zhao, X.8
-
92
-
-
79959364986
-
Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: its association with sequestome 1/p62
-
Myeku N., Figueirido-Pereira M.E. Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: its association with sequestome 1/p62. Journal of Biological Chemistry 2011, 286:22426-22440.
-
(2011)
Journal of Biological Chemistry
, vol.286
, pp. 22426-22440
-
-
Myeku, N.1
Figueirido-Pereira, M.E.2
-
93
-
-
84864805916
-
Autophagy and cancer - issues we need to digest
-
Liu E.Y., Ryan K.M. Autophagy and cancer - issues we need to digest. Journal of Cell Science 2012, 125:1-10.
-
(2012)
Journal of Cell Science
, vol.125
, pp. 1-10
-
-
Liu, E.Y.1
Ryan, K.M.2
|